PV Bulletin

New EU supply chain to end Visudyne shortage

Critical shortage of eye medicine expected to be resolved in 2027.

Primary source: Website data protection notice

PV Impact Brief

Urgency: HighConfidence: high

What changed

The establishment of a new EU supply chain that is anticipated to resolve the critical shortage of Visudyne by 2027.

Why it matters

The end of the shortage will significantly impact the availability of Visudyne, aiding in better safety management and access to necessary medical treatment for patients.

Action needed

Monitor the supply chain developments and prepare to adjust inventory management practices as the end of the shortage approaches.

Relevant for
Signal Management Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 4, 2026

Full briefing

Practical implication

Monitor the supply chain developments and prepare to adjust inventory management practices as the end of the shortage approaches.

The European Medicines Agency has announced that a critical shortage of Visudyne, an eye medicine, is expected to be resolved by 2027 due to the establishment of a new supply chain.

What changed: The establishment of a new EU supply chain that is anticipated to resolve the critical shortage of Visudyne by 2027.

Why it matters: The end of the shortage will significantly impact the availability of Visudyne, aiding in better safety management and access to necessary medical treatment for patients.

Practical implication: Monitor the supply chain developments and prepare to adjust inventory management practices as the end of the shortage approaches.

View original source

  • Source: EMA - What's new RSS
  • Published at source: 2026-09-04T00:00:00.000Z
  • Discovered by monitor: 2026-09-04T21:35:10.446Z

Published from the regulator source ingestion pipeline after PV impact triage.

#Safety Signal#Safety Signals#Source-ingestion#Regulator-monitor#European Union#Ema.europa.eu

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Atellica CH Revised C-Reactive Protein (RCRP) Safety Information - Siemens Healthcare Diagnostics

Urgency: High

Laboratories must implement the safety measures as indicated by the action registration number R2625739, effective from the notice date of September 7, 2026.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward